Insider · CIK 0001913009
Kara Cannon
Files at ENZ (ENZO BIOCHEM INC). First filing -, latest -.
In brief
Kara Cannon files SEC Form 4 as CEO and director at ENZ (ENZO BIOCHEM INC). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Kara Cannon has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 7 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 20, 2025 | ENZ ENZO BIOCHEM INC | DDisposition to issuer Common Stock | -359,737 | - | - | 0 | Aug 20, 2025 |
| Aug 20, 2025 | ENZ ENZO BIOCHEM INC | DDisposition to issuer Common Stockindirect: 401k | -45,065 | - | - | 0 | Aug 20, 2025 |
| Aug 20, 2025 | ENZ ENZO BIOCHEM INC | DDisposition to issuer Stock Option (to acquire shares of Common Stock)derivative | -200,000 | - | - | 0 | Aug 20, 2025 |
| Aug 20, 2025 | ENZ ENZO BIOCHEM INC | DDisposition to issuer Stock Option (to acquire shares of Common Stock)derivative | -200,000 | - | - | 0 | Aug 20, 2025 |
| Aug 20, 2025 | ENZ ENZO BIOCHEM INC | DDisposition to issuer Stock Option (to acquire shares of Common Stock)derivative | -87,500 | - | - | 0 | Aug 20, 2025 |
| Aug 20, 2025 | ENZ ENZO BIOCHEM INC | DDisposition to issuer Stock Option (to acquire shares of Common Stock)derivative | -87,500 | - | - | 0 | Aug 20, 2025 |
| Aug 20, 2025 | ENZ ENZO BIOCHEM INC | DDisposition to issuer Stock Option (to acquire shares of Common Stock)derivative | -55,400 | - | - | 0 | Aug 20, 2025 |
Questions about Kara Cannon
Answered from the filings on this page, as of the latest one.
Is Kara Cannon buying or selling?
Kara Cannon has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Kara Cannon's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Kara Cannon has 0.
Where does Kara Cannon file Form 4?
Kara Cannon has filed Form 4 at ENZ (ENZO BIOCHEM INC) as Chief Executive Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.